SHANGHAI HEARTCARE MEDICAL TECHNOLO
(HKEX: 6609)
Shanghai Heartcare Medical Technology Corp. Ltd. engages in the research, development, manufacture, and sale of neuro-interventional medical devices. Its objective is to redefine the therapeutic and preventive paradigm of stroke. The company was founded by Guo Hui Wang, Kui Ding, and Jia Qi Hong on June 16, 2016 and is headquartered in Shanghai, China.
50.600 -
-1.800
(-3.44%)
Range
49.140 - 52.500
(6.84%)
Open
52.500
Previous Close
52.400
Bid Price
50.650
Bid Volume
('000)
2.1
Ask Price
51.000
Ask Volume
('000)
2.8
Volume
('000)
101.7
Value
5,151,857
Remark
-
Delayed prices. Updated at 13 May 2026 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
